secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEX CORP /DE/ (IEX)
CIK:        0000832101
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0000832101-23-000017
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEX records Q1 sales record, cuts FY2023 adj. EPS guidance amid HST inventory correction; announces acquisition
--------------------------------------------------------------------------------

- Record Q1 sales $845M (+13% YoY); reported EPS $1.84, adjusted EPS $2.09 (+7% vs $1.96).
- Health & Science Technologies inventory correction larger than expected; full-year adjusted EPS guidance lowered to $8.25–$8.55.
- Agreed to acquire Iridian Spectral Technologies for CAD$150M; expected to close Q2 2023.
- Operating cash flow $148M (+86% YoY); free cash flow $121M (+91%).
- FMT segment margin up 50bps to 33.0%, FSDP up 160bps to 28.5%, HST down 300bps to 28.7%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832101/000083210123000017/0000832101-23-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832101/000083210123000017/iex-20230426.htm
  HTML page:      https://secwatch.observer/filing/0000832101-23-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer